Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Ruzsa, Z; Ungi, I; Horváth, T; Sepp, R; Zimmermann, Z; Thury, A; Jambrik, Z; Sasi, V; Tóth, G; Forster, T; Nemes, A.
Five-year experience with transradial coronary angioplasty in ST-segment-elevation myocardial infarction.
Cardiovasc Revasc Med. 2009; 10(2):73-79 Doi: 10.1016/j.carrev.2008.07.004
PubMed FullText FullText_MUG

 

Co-Autor*innen der Med Uni Graz
Toth-Gayor Gabor
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Percutaneous coronary intervention (PCI) via radial approach has been shown to be an alternative to femoral approach in emergency cases; however, its feasibility has been questioned. This single-center study was performed to compare the outcomes and complication rates between transradial (TR) and transfemoral (TF) PCI in ST-segment-elevation myocardial infarction (STEMI). The clinical and angiographic data of 582 consecutive STEMI patients treated with PCI between 2001 and 2006 were evaluated in a retrospective study. Forty-three patients were excluded from the present study due to cardiogenic shock or rescue PCI. Patients (n=539) were categorized into the TR group (n=167) or the TF group (n=372), and several parameters were evaluated to assess the advantages and drawbacks of TR access: access-site crossover, rate of access-site complications, procedure time, fluoroscopy time, X-ray area dose, major adverse cardiac events (MACE) at 1 month, and consumption of angioplasty equipment. In the TR group, the crossover rate to femoral access was 5%, while in the TF group, it was 0.8% (P<.05). There was a significant difference, in both major and minor access-site complications, between the TR group and the TF group (0% vs. 5%, P<.05, and 4% vs. 9%, P<.05, respectively). Consumption of angioplasty equipment proved to be the same for the two groups. The MACE rate was 4% in the TR group and 11% in the TF group (P<.05). Our results suggest that the TR approach is a safe and effective way to treat STEMI; furthermore, site-related complications are less common with this approach.
Find related publications in this database (using NLM MeSH Indexing)
Aged -
Angioplasty, Balloon, Coronary - adverse effects
Angioplasty, Balloon, Coronary - instrumentation
Angioplasty, Balloon, Coronary - methods
Cardiovascular Diseases - etiology
Coronary Angiography -
Female -
Femoral Artery -
Humans -
Male -
Middle Aged -
Myocardial Infarction - diagnostic imaging
Myocardial Infarction - therapy
Platelet Aggregation Inhibitors - therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors
Radial Artery -
Retrospective Studies -
Stents - statistics & numerical data
Time Factors -
Treatment Outcome -

© Med Uni Graz Impressum